Anti-FREM3 functional antibody

Anti-FREM3 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FREM3/FREM3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0929-Ab-1/ GM-Tg-hg-SE0929-Ab-2Anti-Human FREM3 monoclonal antibodyHuman
GM-Tg-rg-SE0929-Ab-1/ GM-Tg-rg-SE0929-Ab-2Anti-Rat FREM3 monoclonal antibodyRat
GM-Tg-mg-SE0929-Ab-1/ GM-Tg-mg-SE0929-Ab-2Anti-Mouse FREM3 monoclonal antibodyMouse
GM-Tg-cynog-SE0929-Ab-1/ GM-Tg-cynog-SE0929-Ab-2Anti-Cynomolgus/ Rhesus macaque FREM3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0929-Ab-1/ GM-Tg-felg-SE0929-Ab-2Anti-Feline FREM3 monoclonal antibodyFeline
GM-Tg-cang-SE0929-Ab-1/ GM-Tg-cang-SE0929-Ab-2Anti-Canine FREM3 monoclonal antibodyCanine
GM-Tg-bovg-SE0929-Ab-1/ GM-Tg-bovg-SE0929-Ab-2Anti-Bovine FREM3 monoclonal antibodyBovine
GM-Tg-equg-SE0929-Ab-1/ GM-Tg-equg-SE0929-Ab-2Anti-Equine FREM3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0929-Ab-1/ GM-Tg-hg-SE0929-Ab-2; GM-Tg-rg-SE0929-Ab-1/ GM-Tg-rg-SE0929-Ab-2;
GM-Tg-mg-SE0929-Ab-1/ GM-Tg-mg-SE0929-Ab-2; GM-Tg-cynog-SE0929-Ab-1/ GM-Tg-cynog-SE0929-Ab-2;
GM-Tg-felg-SE0929-Ab-1/ GM-Tg-felg-SE0929-Ab-2; GM-Tg-cang-SE0929-Ab-1/ GM-Tg-cang-SE0929-Ab-2;
GM-Tg-bovg-SE0929-Ab-1/ GM-Tg-bovg-SE0929-Ab-2; GM-Tg-equg-SE0929-Ab-1/ GM-Tg-equg-SE0929-Ab-2
Products NameAnti-FREM3 monoclonal antibody
Formatmab
Target NameFREM3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FREM3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0929-Ag-1Recombinant multi-species FREM3 protein


    Target information

    Target IDGM-SE0929
    Target NameFREM3
    Gene ID166752,333315,307767,704182,119869397,101087833,781161,100071126
    Gene Symbol and SynonymsFREM3,Gm795,NV2,RGD1562701
    Uniprot AccessionP0C091
    Uniprot Entry NameFREM3_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183090
    Target ClassificationN/A

    The target: FREM3, gene name: FREM3, also named as . This gene encodes an integral membrane protein containing numerous CSPG (chondroitin sulfate proteoglycan element) repeats and Calx-beta domains. The protein belongs to the family of FRAS1/FREM extracellular matrix proteins and may play a role cell adhesion. .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.